Amgen, Inc. (AMGN)
348.07
-5.21
(-1.47%)
USD |
NASDAQ |
Apr 02, 16:00
348.07
0.00 (0.00%)
After-Hours: 17:53
Amgen Shareholders Equity (Quarterly) : 8.658B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Gilead Sciences, Inc. | 22.70B |
| Johnson & Johnson | 81.54B |
| Eli Lilly & Co. | 26.54B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.59B |
| Total Liabilities (Quarterly) | 81.93B |
| Debt to Equity Ratio | 6.403 |
| Current Ratio | 1.14 |
| Net Debt Paydown Yield | 0.56% |